Hideharu Muto

1.1k total citations
16 papers, 160 citations indexed

About

Hideharu Muto is a scholar working on Hematology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Hideharu Muto has authored 16 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hematology, 4 papers in Infectious Diseases and 4 papers in Molecular Biology. Recurrent topics in Hideharu Muto's work include Hematopoietic Stem Cell Transplantation (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Antifungal resistance and susceptibility (3 papers). Hideharu Muto is often cited by papers focused on Hematopoietic Stem Cell Transplantation (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Antifungal resistance and susceptibility (3 papers). Hideharu Muto collaborates with scholars based in Japan. Hideharu Muto's co-authors include Mamiko Sakata‐Yanagimoto, Shigeru Chiba, Naoshi Obara, Naoya Nakamura, Kenichi Yoshida, Kazumi Suzukawa, Seishi Ogawa, Y. Miyake, Hiroyuki Aburatani and Masashi Sanada and has published in prestigious journals such as Blood, CHEST Journal and Leukemia.

In The Last Decade

Hideharu Muto

14 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hideharu Muto Japan 5 70 57 53 51 46 16 160
Helen Marr United Kingdom 10 64 0.9× 32 0.6× 31 0.6× 43 0.8× 65 1.4× 18 188
Esperanza Lavilla Spain 8 65 0.9× 82 1.4× 49 0.9× 23 0.5× 100 2.2× 12 200
Christos Demosthenous Greece 8 71 1.0× 77 1.4× 20 0.4× 47 0.9× 61 1.3× 19 202
Fernando Roncolato Australia 8 57 0.8× 109 1.9× 66 1.2× 14 0.3× 39 0.8× 17 183
Zoé Van de Wyngaert France 8 81 1.2× 138 2.4× 25 0.5× 26 0.5× 68 1.5× 22 191
Stefan Köhrer Austria 4 69 1.0× 32 0.6× 54 1.0× 30 0.6× 42 0.9× 11 153
Ranjit Banwait United States 8 68 1.0× 73 1.3× 149 2.8× 67 1.3× 33 0.7× 25 248
Fabienne Lucas United States 8 68 1.0× 77 1.4× 38 0.7× 60 1.2× 51 1.1× 22 192
Jana Mihályová Czechia 7 90 1.3× 84 1.5× 57 1.1× 71 1.4× 136 3.0× 16 251
Peter Tan Australia 10 109 1.6× 126 2.2× 14 0.3× 85 1.7× 55 1.2× 18 252

Countries citing papers authored by Hideharu Muto

Since Specialization
Citations

This map shows the geographic impact of Hideharu Muto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideharu Muto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideharu Muto more than expected).

Fields of papers citing papers by Hideharu Muto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideharu Muto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideharu Muto. The network helps show where Hideharu Muto may publish in the future.

Co-authorship network of co-authors of Hideharu Muto

This figure shows the co-authorship network connecting the top 25 collaborators of Hideharu Muto. A scholar is included among the top collaborators of Hideharu Muto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideharu Muto. Hideharu Muto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
2.
Kaito, Satoshi, Hideharu Muto, Shuichi Miyawaki, Kazuteru Ohashi, & Junji Tomiyama. (2019). Timely Diagnosis and Successful Treatment of Intravascular Large B-Cell Lymphoma in an Elderly Patient with Poor Performance Status. American Journal of Case Reports. 20. 780–784. 2 indexed citations
3.
Kato, Takafumi, Hideharu Muto, Tsunekazu Hishima, et al.. (2018). A 56-Year-Old Woman With Multiple Pulmonary Cysts and Severe Chest Pain. CHEST Journal. 153(5). e105–e112. 3 indexed citations
4.
Shingai, Naoki, Satoshi Kaito, Yuta Yamada, et al.. (2018). Reassessment of clinical implication of pretransplant surgical procedures for pulmonary invasive fungal lesions. Transplant Infectious Disease. 21(1). 1 indexed citations
5.
Kaito, Satoshi, Yuho Najima, Tatsuya Konishi, et al.. (2017). Post-Transplant Maintenance Therapy with Azacitidine and Gemtuzumab Ozogamicin for High-Risk Hematologic Malignancies. Blood. 130. 4517–4517. 4 indexed citations
6.
Harada, Kaito, Yuta Yamada, Tatsuya Konishi, et al.. (2016). Comparison of transplant outcomes and economic costs between biosimilar and originator filgrastim in allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 104(6). 709–719. 3 indexed citations
7.
Sakata‐Yanagimoto, Mamiko, Keiichiro Hattori, Hideharu Muto, et al.. (2016). BCL6 locus is hypermethylated in angioimmunoblastic T-cell lymphoma. International Journal of Hematology. 105(4). 465–469. 22 indexed citations
8.
9.
Kato, Takeharu, Mamiko Sakata‐Yanagimoto, Hidekazu Nishikii, et al.. (2014). Hes1 suppresses acute myeloid leukemia development through FLT3 repression. Leukemia. 29(3). 576–585. 34 indexed citations
10.
Muto, Hideharu, Mamiko Sakata‐Yanagimoto, Genta Nagae, et al.. (2014). Reduced TET2 function leads to T-cell lymphoma with follicular helper T-cell-like features in mice. Blood Cancer Journal. 4(12). e264–e264. 68 indexed citations
11.
Muto, Hideharu, Mamiko Sakata‐Yanagimoto, Y. Miyake, et al.. (2013). Hypermethylation of Bcl6 Is a Potential Cause of Development of Lymphoma with Tfh Features in Tet2 Knockdown Mice. Blood. 122(21). 2490–2490. 1 indexed citations
12.
Muto, Hideharu, Kazuteru Ohashi, Minoru Ando, Hideki Akiyama, & Hisashi Sakamaki. (2010). Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation. International Journal of Hematology. 91(3). 471–477. 16 indexed citations
13.
Muto, Hideharu, Kazuteru Ohashi, Minoru Ando, et al.. (2008). Cystatin C Level as a Marker of Renal Function in Hematopoietic Stem Cell Transplantation. Blood. 112(11). 4306–4306. 1 indexed citations
14.
15.
16.
Muto, Hideharu, Kunihiro Yamagata, Mariko Inoue, et al.. (2005). Acute Multifocal Bacterial Nephritis Complicated with Acute Renal Failure and Thrombocytopenia. Internal Medicine. 44(10). 1084–1087. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helen Marr Breakdown of academic impact, for papers by Esperanza Lavilla Breakdown of academic impact, for papers by Christos Demosthenous Breakdown of academic impact, for papers by Fernando Roncolato Breakdown of academic impact, for papers by Zoé Van de Wyngaert Breakdown of academic impact, for papers by Stefan Köhrer Breakdown of academic impact, for papers by Ranjit Banwait Breakdown of academic impact, for papers by Fabienne Lucas Breakdown of academic impact, for papers by Jana Mihályová Breakdown of academic impact, for papers by Peter Tan
Rankless by CCL
2026